Houston Chronicle by Todd Ackerman Nov. 9, 2020
Hundreds of Galveston area residents and workers are participating in the clinical trial of a coronavirus vaccine that early data released Monday showed was highly effective, rare hopeful news about the effort to contain the global pandemic.
The data, contained in a Pfizer press release, suggested the company’s vaccine may be more than 90 percent effective at preventing symptomatic COVID-19, much more than was anticipated for any of the candidates in late-stage clinical trials. The Pfizer vaccine is the first to generate such late-stage data.
“Tentatively, this looks like good news,†said Peter Hotez, a vaccine scientist at Baylor College of Medicine, which is testing another vaccine. “It was written for Pfizer shareholders, not scientists, and the company still has a ways to go - determining whether the vaccine halts severe disease and proves to be safe — before the FDA grants emergency approval. But this appears to be an important first step.â€
More:
https://www.houstonchronicle.com/neighborhood/galveston/article/galveston-covid-vaccine-appears-effective-hundreds-15713362.php
